A long-term, trust-based CDMO partnership can support cell and gene therapy developers from early process development through GMP manufacturing and commercial supply.
Fujifilm
Advertisement
Articles by Fujifilm
Jonathan Haigh, Head of UK Sites, FUJIFILM Biotechnologies, explores how advanced technologies are being used to reduce risk and strengthen global supply chains for biologics.
Biopharmaceutical manufacturers can strategically choose between fed-batch and continuous manufacturing to balance scalability, flexibility, and market demand across the product lifecycle.
Webinar Date/Time: Tue, Mar 4, 2025 11:00 AM EST
Achieving High Productivities through Bioreactor Optimization at Lower than Peak Cell Densities in a Perfusion Process
ByFujifilm
Webinar Date/Time: Wed, Dec 4, 2024 11:00 AM EST
Webinar Date/Time: Wed, Dec 6, 2023 11:00 AM EST
Advertisement
Latest Updated Articles
Achieve Higher mAb Titers with BalanCD CHO Perfusion and BalanCD CHO DG44Published: November 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
3
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
4
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
5